Clinical Trial Update: Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy Adults [Phase 1]

View source ↗

Summary

A phase 1 dose-escalation study evaluated the safety and potential efficacy of MG1111 in healthy adults; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• MG1111

Snippet

Sponsor: Green Cross Corporation | Conditions: Varicella (Chicken Pox) | Phase 1 | Status: COMPLETED